FDA Inspection 1180862 — NUVOAIR AB
The FDA completed an inspection of NUVOAIR AB on Sep 22, 2022 in Stockholm. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 22, 2022
- Fiscal Year
- 2022
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Stockholm (Sweden)